Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Clinical development of phosphatidylinositol 3-kinase inhibitors for cancer treatment

BMC Medicine201210:161

DOI: 10.1186/1741-7015-10-161

Received: 20 July 2012

Accepted: 11 December 2012

Published: 11 December 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
20 Jul 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
27 Aug 2012 Reviewed Reviewer Report - Hendrik-Tobias Arkenau
10 Sep 2012 Reviewed Reviewer Report - kyriakos papadopoulos
Resubmission - Version 5
Submitted Manuscript version 5
1 Oct 2012 Author responded Author comments - Alice Holt
Resubmission - Version 6
1 Oct 2012 Submitted Manuscript version 6
1 Oct 2012 Author responded Author comments - Alice Holt
Resubmission - Version 7
1 Oct 2012 Submitted Manuscript version 7
1 Oct 2012 Author responded Author comments - Alice Holt
Resubmission - Version 8
1 Oct 2012 Submitted Manuscript version 8
10 Oct 2012 Reviewed Reviewer Report - Hendrik-Tobias Arkenau
Resubmission - Version 9
Submitted Manuscript version 9
Publishing
11 Dec 2012 Editorially accepted
11 Dec 2012 Article published 10.1186/1741-7015-10-161

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Drug Development Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto

Advertisement